Safety of Aripiprazole with Warfarin

Monitoring Recommendations

Standard INR monitoring should continue as routinely recommended for all patients on warfarin therapy, according to the American Heart Association, as stated in Circulation: Arrhythmia and Electrophysiology 1
The American Heart Association recommends following the usual protocol for monitoring warfarin therapy, including more frequent INR checks during any medication changes, as published in Circulation: Arrhythmia and Electrophysiology 2
Be vigilant for any unexpected changes in INR values, as individual patient responses can vary, as noted in Circulation: Arrhythmia and Electrophysiology 1

Patients taking warfarin have been excluded from clinical trials evaluating other medications like ibrutinib, according to the National Comprehensive Cancer Network 3, 4
If the patient is taking multiple medications, evaluate the complete medication profile for potential drug interactions with warfarin, as recommended by the American Heart Association, in Circulation: Arrhythmia and Electrophysiology 1
Antibiotics, particularly sulfonamides, can significantly interact with warfarin and nearly double the risk of serious bleeding, as reported in a medical journal 5

Check baseline INR before starting aripiprazole, as recommended by the American Heart Association, in Circulation: Arrhythmia and Electrophysiology 1
Monitor INR according to standard warfarin monitoring protocols, according to the American Heart Association, as published in Circulation: Arrhythmia and Electrophysiology 2
Be particularly vigilant during the first few weeks of co-administration, as noted in Circulation: Arrhythmia and Electrophysiology 1
Continue routine monitoring as long as both medications are administered, as recommended by the American Heart Association, in Circulation: Arrhythmia and Electrophysiology 2